- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-1596
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The predictive significance of CD20 expression in B-cell lymphomas ; volume:6 ; number:1 ; day:12 ; month:4 ; year:2011 ; pages:1-6 ; date:12.2011
Diagnostic pathology ; 6, Heft 1 (12.4.2011), 1-6, 12.2011
- Urheber
-
Prevodnik, Veronika Kloboves
- Beteiligte Personen und Organisationen
-
Lavrenčak, Jaka
Horvat, Mateja
Novakovič, Barbara Jezeršek
SpringerLink (Online service)
- DOI
-
10.1186/1746-1596-6-33
- URN
-
urn:nbn:de:1111-2016080739089
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Prevodnik, Veronika Kloboves
- Lavrenčak, Jaka
- Horvat, Mateja
- Novakovič, Barbara Jezeršek
- SpringerLink (Online service)
Ähnliche Objekte (12)
Diagnosis and treatment of CD20 negative B cell lymphomas
Bioinformatical analysis of B-cell lymphomas
TOX expression in cutaneous B-cell lymphomas
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Epigenetic-mediated apoptosis in aggressive B-cell lymphomas
Tumor Evolution through Differentiation in B-Cell Lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas
Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody
Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas
Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
Aggressive B‐cell lymphomas with a primary bone marrow presentation
COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma
Diagnosis and treatment of CD20 negative B cell lymphomas
Bioinformatical analysis of B-cell lymphomas
TOX expression in cutaneous B-cell lymphomas
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Epigenetic-mediated apoptosis in aggressive B-cell lymphomas
Tumor Evolution through Differentiation in B-Cell Lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas
Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody
Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas
Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
Aggressive B‐cell lymphomas with a primary bone marrow presentation
COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma
Diagnosis and treatment of CD20 negative B cell lymphomas
Bioinformatical analysis of B-cell lymphomas
TOX expression in cutaneous B-cell lymphomas
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Epigenetic-mediated apoptosis in aggressive B-cell lymphomas
Tumor Evolution through Differentiation in B-Cell Lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas
Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody
Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas
Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
Aggressive B‐cell lymphomas with a primary bone marrow presentation